Bevac (Hepatitis B rDNA) for IM injection Multi Dose

Bevac (Hepatitis B rDNA) Vaccine for Intramuscular Injection is a WHO-prequalified recombinant Hepatitis B vaccine manufactured by Biological E. Limited, designed for healthcare professionals administering routine immunization programs. This prescription-only injection stimulates immune response to produce protective antibodies against Hepatitis B virus (HBV), preventing acute infection, chronic liver disease, cirrhosis, and hepatocellular carcinoma.

Key Clinical Specifications:

Administration: Intramuscular injection delivered by licensed healthcare professionals to the deltoid muscle (adults/adolescents) or anterolateral thigh (infants).

Immunization Schedule: Standard three-dose series administered at 0, 1, and 6 months; neonatal schedules begin at birth per national immunization guidelines.

Storage Requirements: Maintain continuous cold chain at 2–8°C; do not freeze. Shelf life of 36 months under proper refrigeration.

Formulation: Liquid presentation in multi-dose vials with thiomersal preservative (0.025 mcg/mL); VVM Type 30 indicator included.

Expected Safety Profile: Localized injection-site reactions (soreness, erythema, induration), systemic responses (low-grade fever, fatigue, headache) are typically mild and transient.

Regulatory Status: Current WHO prequalification ensures compliance with international immunization standards and procurement eligibility for public health programs.

Ideal for clinic networks, immunization centers, and pharmacy-dispensed vaccination services requiring reliable, cold-chain-stable hepatitis B prophylaxis.